Non-modulating essential hypertension: renal hemodynamic effects of long-term angiotensin converting enzyme inhibition
Ramirez, A.J.; Migliorini, M.; Gilbert, B.H.; Marco, E.J.; Sanchez, R.A.
Journal of Hypertension. Supplement Official Journal of the International Society of Hypertension 9(6): S396-S397
1991
ISSN/ISBN: 0952-1178 PMID: 1819004 Document Number: 376542
Document emailed within 1 workday
Related Documents
Rasmussen, S.; Ibsen, H.; Giese, J. 1984: Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension Scandinavian Journal of Urology and Nephrology. Supplementum 79: 49-52Tajima, J.; Abe, K.; Yasujima, M.; Tanno, M.; Yoshinaga, K. 1984: Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension Nihon Jinzo Gakkai Shi 26(6): 779-789
Kutkuhn, B.; Chlebowski, H.; Hollenbeck, M.; Grabensee, B. 1989: Conversion of inactive renin to active renin following acute angiotensin converting enzyme inhibition in essential hypertension and renovascular hypertension Zeitschrift für Kardiologie 78(3): 204-210
Zeravica, R.; Stosić, Z.; Ilincić, B.; Crnobrnja, V.; Jakovljević, A.; Mijović, R. 2014: The effect of angiotensin converting enzyme inhibition on effective renal plasma flow in patients with diffuse renal parenchymal diseases and hypertension Medicinski Pregled 67(3-4): 78-82
Levenson, D.J.; Dzau, V.J. 1987: Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis Kidney International. Supplement 20: S173-S179
Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M. 1985: Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension Nihon Jinzo Gakkai Shi 27(11): 1571-1583
Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Katel'nitskaia, L.I.; Ivanchenko, D.N.; Khansheva, L.A.; Kholoshina, L.V.; Glova, S.E.; Pleskachev, S.A. 2006: Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril Kardiologiia 46(3): 35-38
Schiffrin, E.L.; Deng, L.Y.; Larochelle, P. 1994: Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension Archives des Maladies du Coeur et des Vaisseaux 87(8): 979-981
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428
Bakaev, R.G.; Strutynskiĭ, A.V.; Kallaeva, A.N.; Glazunov, A.B.; Voronina, M.A.; Pekhtereva, D.A.; Moshkova, N.K.; Chudnovskaia, E.A.; Kochetkov, B.M. 2011: Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction Klinicheskaia Meditsina 89(1): 23-26
Ryan, E.; Muldowney, F.P. 1983: Use of angiotensin i to Ii converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension Irish Medical Journal 76(4): 175; 177-178
Humke, U.; Levens, N.; Wood, J.; Hofbauer, K. 1992: The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system Journal of Pharmacology and Experimental Therapeutics 260(1): 29-35
Santucci, A.; Aguglia, F.; De Mattia, G.; Cammarella, I.; Trinchieri, F.; Giordano, M.; Gnecchi, M.; Ficara, C. 1983: Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin i converting enzyme La Clinica Terapeutica 106(2): 121-124
Lin, M.; Chiang, H.T.; Chen, C.Y. 1991: Comparisons of long-term effects between converting enzyme inhibitors and conventional therapy in treating mild to moderate hypertension Zhonghua Yi Xue Za Zhi 48(5): 339-350
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Spinale, F.G.; Holzgrefe, H.H.; Mukherjee, R.; Webb, M.L.; Hird, R.B.; Cavallo, M.J.; Powell, J.R.; Koster, W.H. 1997: Angiotensin-converting enzyme inhibition and angiotensin Ii subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes Journal of Pharmacology and Experimental Therapeutics 283(3): 1082-1094
Shand, B.I.; Bailey, R.R. 1994: Treatment of erythrocytosis in a renal transplant recipient by angiotensin converting enzyme inhibition New Zealand Medical Journal 107(973): 90
Ingert, C.; Grima, M.; Michel, B.; Barthelmebs, M.; Imbs, J.L. 1997: Renal tissue angiotensins during converting enzyme inhibition of angiotensin i in spontaneously hypertensive rat Archives des Maladies du Coeur et des Vaisseaux 90(8): 1135-1141
Fagard, R.; Amery, A.; Lijnen, P.; Roussel-Deruyck, R. 1982: Discrimination of renovascular from essential hypertension by converting enzyme inhibition with an orally active compound Acta Clinica Belgica 37(1): 13-22